|
private:appliedstemcell
|
1066555
|
Nov 18th, 2019 12:00AM
|
Applied StemCell
|
2.6K
|
82.00
|
Open
|
Biotechnology
|
Nov 18th, 2019 03:42PM
|
Nov 18th, 2019 03:42PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|
|
private:appliedstemcell
|
1066555
|
Nov 16th, 2019 12:00AM
|
Applied StemCell
|
2.6K
|
82.00
|
Open
|
Biotechnology
|
Nov 16th, 2019 03:53PM
|
Nov 16th, 2019 03:53PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|
|
private:appliedstemcell
|
1066555
|
Nov 15th, 2019 12:00AM
|
Applied StemCell
|
2.5K
|
82.00
|
Open
|
Biotechnology
|
Nov 15th, 2019 12:35PM
|
Nov 15th, 2019 12:35PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|
|
private:appliedstemcell
|
1066555
|
Nov 14th, 2019 12:00AM
|
Applied StemCell
|
2.5K
|
82.00
|
Open
|
Biotechnology
|
Nov 14th, 2019 05:50PM
|
Nov 14th, 2019 05:50PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|
|
private:appliedstemcell
|
1066555
|
Nov 13th, 2019 12:00AM
|
Applied StemCell
|
2.5K
|
82.00
|
Open
|
Biotechnology
|
Nov 13th, 2019 01:02PM
|
Nov 13th, 2019 01:02PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|
|
private:appliedstemcell
|
1066555
|
Nov 12th, 2019 12:00AM
|
Applied StemCell
|
2.5K
|
82.00
|
Open
|
Biotechnology
|
Nov 12th, 2019 02:45PM
|
Nov 12th, 2019 02:45PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|
|
private:appliedstemcell
|
1066555
|
Nov 11th, 2019 12:00AM
|
Applied StemCell
|
2.5K
|
82.00
|
Open
|
Biotechnology
|
Nov 11th, 2019 02:43PM
|
Nov 11th, 2019 02:43PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|
|
private:appliedstemcell
|
1066555
|
Nov 10th, 2019 12:00AM
|
Applied StemCell
|
2.5K
|
82.00
|
Open
|
Biotechnology
|
Nov 10th, 2019 05:49PM
|
Nov 10th, 2019 05:49PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|
|
private:appliedstemcell
|
1066555
|
Nov 9th, 2019 12:00AM
|
Applied StemCell
|
2.5K
|
82.00
|
Open
|
Biotechnology
|
Nov 9th, 2019 05:16PM
|
Nov 9th, 2019 05:16PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|
|
private:appliedstemcell
|
1066555
|
Nov 8th, 2019 12:00AM
|
Applied StemCell
|
2.5K
|
82.00
|
Open
|
Biotechnology
|
Nov 8th, 2019 02:27PM
|
Nov 8th, 2019 02:27PM
|
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. ASC welcomes your comments, suggestions and ideas.
Establishing cell models
Establishing disease-specific isogenic models
Developing master cell lines for antibody/protein production
Generating iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications
Generating animal models (mouse/rat models)
Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.
For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
|
Open
|
Genome Editing, Mouse Rat Model Generation, Cell Line Models, iPSC Disease Modeling, iPSC Differentiation, iPSC Tox Study, iPSC Generation, Reference Standards, Isogenic Cell Lines, Phonetype Screening, FFPE , Contract Research, Stem Cell Culture, Bioproduction, CRISPR/Cas9, Cancer Research, Neuro Disease Research, Genomics, Virus Packaging, Safe Harbor Locus, antibody production, Antibody screening, antibody discovery, Bioproduction
|
Open
|
521 Cottonwood Drive, Suite 111
|
Milpitas
|
CA
|
US
|
95035
|
|
Applied StemCell
|
|
Health Care Equipment & Services
|